Compare CRVS & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRVS | WEYS |
|---|---|---|
| Founded | 2014 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 459.0M | 280.9M |
| IPO Year | 2016 | N/A |
| Metric | CRVS | WEYS |
|---|---|---|
| Price | $8.57 | $30.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $13.75 | N/A |
| AVG Volume (30 Days) | ★ 945.3K | 19.8K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 3.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.54 |
| Revenue | N/A | ★ $279,843,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.54 | $25.51 |
| 52 Week High | $9.60 | $38.24 |
| Indicator | CRVS | WEYS |
|---|---|---|
| Relative Strength Index (RSI) | 54.47 | 52.32 |
| Support Level | $8.03 | $30.20 |
| Resistance Level | $9.17 | $31.88 |
| Average True Range (ATR) | 0.55 | 1.01 |
| MACD | -0.06 | 0.09 |
| Stochastic Oscillator | 38.22 | 73.73 |
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.